Whole exome sequencing gives additional benefits compared to candidate gene sequencing in the molecular diagnosis of children with growth hormone or IGF-1 insensitivity
European Journal of Endocrinology Sep 08, 2017
Shapiro , et al. - Aim of this work was to distinguish the underlying genetic diagnoses in a paediatric cohort with GH or IGF-1 insensitivity using candidate gene (CGS) and whole exome sequencing (WES) and evaluate factors correlated with the discovery of a genetic defect. Importantly, comprehensive genetic testing validates the genetic heterogeneity of GH/IGF-1 insensitivity and successfully distinguished the genetic aetiology in a significant proportion of cases. The data demonstrated that WES is rapid and may isolate genetic variants that have been missed by traditional clinically driven genetic testing. This emphasises the benefits of specialist diagnostic centres.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries